MicrobiomePost discussed with Claire Derlot, Head of Programs at Biose Industrie, the GMP challenges when you have to go from bacteria to a drug.
Rebyota is the first and only FDA-approved Microbiome-Based Treatment for the prevention of recurrence of C. diff infection in adults.
The findings of a recent study suggest that the availability of iron can reshape the composition of the gut microbiota in irreversible ways.
Chicago-based company said it invested more than $30 million to help meet rising global demand
The findings of a recent study suggest that the microbiota can promote neuronal repair after tissue damage.
MicrobiomePost talked with Isabelle de Cremoux, CEO of Seventure Partners, about the news that will emerge in 2023.
Consumers would like to be more informed on the labelling and in communications about probiotic food, and about probiotic microorganisms in food and food supplements.
The findings of a recent study may inform dietary interventions to help protect people against type 1 diabetes and other autoimmune diseases.
Collaboration joins MD Anderson's expertise and capabilities with Fed Bio's proprietary ACT bacterial cell therapy platform to design and manufacture a complex, synthetic microbiome-based therapy
The findings of a recent study advance our understanding of bacterial dysbiosis in Crohn’s disease and may inform new therapeutic strategies.
